Analyzing Healthcare

Roy Bejarano and Jason Schifman Scale Healthcare
Analyzing Healthcare

What’s next for healthcare? In a rapidly evolving industry, staying ahead requires insights, expert analysis, and actionable strategies. Analyzing Healthcare is the podcast for healthcare professionals, policymakers, investors, and curious citizens who want to navigate the challenges and opportunities shaping the future of healthcare. Analyzing Healthcare goes beyond theory to deliver real-world case studies and perspectives on the U.S. and global healthcare system. Hosted by industry experts Roy Bejarano and Jason Schifman, Co-Founders of SCALE Healthcare, the country’s leading healthcare services consulting firm, the podcast explores the ever changing world of our healthcare industry. Whether you’re eager to ignite new ideas, broaden your knowledge, or enjoy stimulating discussions, Analyzing Healthcare offers something for everyone. Each episode features thought-provoking conversations with healthcare political leaders, CEOs and innovators, to authors and visionaries, tackling today’s most pressing topics, including a macro understanding of how to evaluate our health system on a global basis, digital health advancements, artificial intelligence in healthcare, value-based care models, telemedicine trends, healthcare policy and regulatory changes. Learn how top professionals are improving patient outcomes, streamlining operations, and driving innovation in this dynamic field. Whether you’re focused on healthcare management, investing in healthcare services, or simply passionate about staying informed, this podcast empowers you with the tools and knowledge to succeed. Join us as we explore the subjects that influence all of our lives and encourage you to join the dialogue. Stay ahead of the curve—subscribe to Analyzing Healthcare with Roy Bejarano and Jason Schifman and explore the groundbreaking trends and strategies defining the future of healthcare. Head on over to www.scale-community.com to become a Scale Community Member. Join us next time, where stories, insights, and inspiration await. About the Hosts Roy Bejarano is the Co-Founder and CEO of SCALE Healthcare, named the #1 Fastest Growing Consulting Firm in the U.S. by Consulting Magazine in 2022. Since founding the company in 2019, Roy’s team has collaborated with hundreds of multi-site provider organizations and financial institutions, focusing on MSO operations, practice management, and strategic healthcare dynamics. Previously, Roy co-founded Frontier Healthcare, New York’s largest ASC management company at the time of its sale to Physicians Endoscopy/Kelso Private Equity. He also served as Chief Strategy Officer & Co-President of Physicians Endoscopy’s MSO initiative, leading its inaugural physician practice MSO partnership. Before entering healthcare, Roy gained over a decade of experience in investment banking, private equity, and strategic consulting with firms like Houlihan Lokey and Citigroup. A frequent author and speaker on healthcare trends, Roy has contributed to Fast Company, Physicians Practice, and Beckers and presented at leading industry conferences. Jason Schifman is the Co-Founder & President of SCALE Healthcare. SCALE provides both the broadest and deepest range of services & solutions available to multi-site healthcare management teams today, based on our fundamental belief that narrow, and/or purely theoretical solutions cannot solve for the multidisciplinary opportunities and challenges of today’s healthcare market. Jason is a trusted advisor to an extensive range of multisite healthcare organizations, Boards, CEOs, private equity investors and lenders across the healthcare market. He has advised stakeholders on a broad range of strategic, growth & development and operational objectives. Internally, Jason is focused on overseeing SCALE’s management leadership team, as well as leading the development and expansion of SCALE’s portfolio of services and innovation initiatives.

  1. 4D AGO · VIDEO

    The Future of Cardiovascular Care Tech Tailored for Women with Dr. Suzanne Steinbaum

    In this podcast episode, Jason Schifman interviews Suzanne Steinbaum, founder and CEO of Adesso, a company dedicated to improving cardiovascular care for women. They discuss the alarming statistics surrounding women's heart health, the unique challenges faced by female patients, and how Adesso's tailored care management platform aims to address these issues. The conversation covers the importance of prevention, the differences in treatment between men and women, and the innovative approach Adesso takes to engage patients and improve outcomes. Suzanne shares insights on the company's growth strategy, partnerships, and future developments in their platform. Title: The Future of Cardiovascular Care Tech Tailored for Women with Dr. Suzanne Steinbaum Key Timestamps: * (00:00) Introduction to Cardiovascular Care for Women* (02:53) Understanding the Statistics: Women's Heart Health* (05:57) The Unique Challenges of Women's Cardiovascular Disease* (09:07) Introducing Adesso: A Tailored Care Management Platform* (11:47) Patient Experience: Standard Care vs. Adesso's Approach* (15:09) Ongoing Care and Patient Engagement with Adesso* (17:54) Adesso's Market Footprint and Growth Strategy* (21:07) Partnerships and Coordination in Cardiovascular Care* (23:52) Data-Driven Care: Algorithms and Outcomes* (27:00) Future Directions and Product Development for Adesso* (30:10) Challenges in Scaling and Replicating Success Key Takeaways: * One in three women die of heart disease, more than all cancers combined.* 80% of heart disease is preventable, highlighting the need for prevention strategies.* Women experience heart disease differently than men, often with worse outcomes.* Adesso focuses on a tailored approach to cardiovascular care for women.* The platform integrates with primary care to manage heart health proactively.* Patient engagement is crucial; Adesso uses an app for ongoing communication.* The company has seen a significant re-engagement of patients through its platform.* Adesso is expanding its reach through partnerships with ACOs and other healthcare providers.* Data-driven algorithms are used to assess patient risk and guide treatment.* Future developments include a men's version of the platform and integration of various health management solutions. About the Guest:Dr. Suzanne Steinbaum, a leading cardiologist, entrepreneur, and advocate for women's heart health. With decades of experience at top hospitals, she pioneers technology-driven solutions to prevent heart disease. Through Adesso she is reshaping cardiac care and empowering women to take control of their heart health. Keywords:Cardiovascular Care, Women's Health, Heart Disease Prevention, Adesso, Healthcare Technology, Patient Engagement, Care Management, Health Statistics, Women's Heart Health, Preventive Care, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare, Healthcare Leadership, Healthcare Trends

  2. MAR 12 · VIDEO

    Private Equity Under the Microscope: Incentives, Liability, and the Transactional Truth with Brendan Ballou

    Roy Bejarano hosts Brendan Ballou on Analyzing Healthcare to discuss his book Plunder and private equity’s impact on the U.S. economy. Ballou explores its dual nature—value creation vs. short-term risks—along with legal and regulatory challenges. The conversation covers ownership dynamics, risk management, and transaction implications. It highlights private equity’s conservative approach, healthcare investments, and the need for greater transparency and accountability. Title: Private Equity Under the Microscope: Incentives, Liability, and the Transactional Truth with Brendan Ballou Key Timestamps: * (00:00) Introduction to Private Equity and Brendan Ballou* (03:05) The Research Behind 'Plunder' and Private Equity's Impact* (06:12) The Dual Nature of Private Equity: Pillaging vs. Building* (08:54) Regulatory Challenges and Public Perception of Private Equity* (11:51) Incentives and Fee Structures in Private Equity* (14:55) Long-term vs. Short-term Perspectives in Private Equity* (18:12) The Role of Legal Incentives in Private Equity* (21:01) Conclusion: Balancing Perspectives on Private Equity* (27:37) Understanding Private Equity Ownership Dynamics* (30:01) The Risk Landscape in Private Equity* (33:57) Transaction Risks and Their Implications* (40:18) Private Equity's Focus on Healthcare Investments* (52:23) Regulatory Considerations and Industry AccountabilityKey Takeaways: * Plunder critiques private equity’s impact on America.* Private equity firms often shield themselves from legal consequences.* Fee structures incentivize short-term gains.* Many private equity portfolios have a 90% success rate.* Legal incentives can misalign firm interests.* Public perception is often negative due to anecdotal cases.* Long-term investment approaches yield better results.* Private equity professionals are not inherently malicious.* Regulatory challenges remain significant.* A balanced view is needed for informed discussions.* Ownership can be majority or minority, affecting control.* Transaction risks outweigh litigation risks.* Ownership changes introduce governance challenges.* Private equity firms tend to be conservative and risk-averse.* Investment bankers shape transaction risk landscapes.* Healthcare investments are often misrepresented.* Regulatory frameworks need updates for accountability.* Transparency is key to building public trust.* Inflated valuations pose systemic risks.* Risk management is often reactive, not proactive.⁠⁠linkedin.com/in/brendan-ballou-2546801b7⁠⁠ (linkedin.com/in/brendan-ballou-2546801b7)⁠⁠www.scale-community.com ⁠⁠ (www.scale-community.com) About the Guest: Brendan Ballou, author of "Plunder," critically examines private equity's influence on America. As a former federal prosecutor, including Special Counsel for Private Equity at the Justice Department, he brings unique legal insight. Ballou exposes risks like excessive debt and limited liability, driving vital discussions on industry regulation and its societal impact. His work sparks debate on accountability and economic fairness. Keywords: Private Equity, Brendan Ballou, Plunder, Legal Incentives, Short-term Thinking, Long-term Investment, Regulatory Challenges, Fee Structures, Public Perception, Healthcare, private equity, ownership dynamics, risk management, healthcare investments, regulatory accountability, transaction risks, investment strategies, legal insulation, corporate governance, financial incentives, Analyzing Healthcare, Roy Bejarano, Jason Schifman,

  3. MAR 10 · VIDEO

    Revolutionizing Heart Care: How CVAUSA is Transforming Cardiology with Innovation, Risk-Based Models, and Patient-Centric Solutions

    In this episode, Tim Atterbury, CEO of Cardiovascular Associates of America (CVA USA), discusses the innovative approaches and structural changes being implemented in the cardiovascular care sector. He emphasizes the importance of empowering entrepreneurial cardiologists, integrating various aspects of care delivery, and navigating the complexities of risk-based reimbursement models. The conversation highlights the need for innovation, experimentation, and collaboration within the healthcare ecosystem to improve patient outcomes and reduce costs. This conversation delves into the evolving landscape of cardiology, focusing on patient management, collaborative care models, and the importance of risk-based contracting. The speakers discuss the challenges and opportunities presented by technology, strategic partnerships, and the role of private equity in shaping the future of healthcare. Emphasis is placed on the need for transparency and sustainability in operations, as well as the importance of adapting to geographic constraints and market dynamics.Title: How CVAUSA is Transforming Cardiology with Innovation, Risk-Based Models, and Patient-Centric Solutions with Tim Attebery Key Timestamps: * (00:00) Introduction to CVA USA and Its Mission* (02:49) The Evolution of Cardiovascular Care* (05:46) Building a Comprehensive Care Model* (09:09) Innovative Approaches to Patient Care* (12:07) Risk-Based Reimbursement in Cardiology* (15:02) Fostering Innovation and Experimentation* (18:13) Navigating the Future of Cardiovascular Care* (28:41) Understanding Patient Management in Cardiology* (30:01) Collaborative Care Models with Primary Care* (32:45) Risk-Based Contracting in Cardiology* (34:40) Geographic Constraints in Risk Models* (35:42) Exploring Strategic Partnerships* (37:27) Impact of Technology in Cardiology* (41:43) Building a Modern MSO* (46:02) Future Challenges in Cardiology* (49:19) The Role of Private Equity in HealthcareKey Takeaways: * CVA USA has 160+ locations and 550+ providers.* The mission is to empower specialists to improve care.* Clinical, operational, and financial integration is key.* Data analytics and advanced practice providers are vital.* Risk-based contracting helps control patient care costs.* Home-based cardiac rehab improves accessibility.* Innovation and transparency are encouraged.* CVA USA manages the full spectrum of cardiovascular care.* The goal is quality care while reducing avoidable costs.

  4. MAR 5 · VIDEO

    Analyzing Healthcare: Pioneering Innovation in Regenerative Medicine and Stem Cell Therapy With Dr. Robin Smith

    Roy Bejarano sits down with Dr. Robin Smith and Dr. Andrew Von Eschenbach as they delve into the evolving field of regenerative medicine, focusing on stem cell therapy and its applications. In this episode, they discuss the history, current trends, and future potential of regenerative medicine, emphasizing the importance of exosomes and the challenges faced in clinical trials and FDA approval processes. They highlight the promise of regenerative therapies in restoring health and the need for continued innovation in healthcare. Title: Pioneering Innovation in Regenerative Medicine and Stem Cell Therapy with Dr. Robin Smith Guests: Dr. Robin Smith & Dr. Andrew Von Eschenbach Key Timestamps: * (00:00) Introduction to Regenerative Medicine * (03:11) The Evolution of Stem Cell Therapy * (05:50) Understanding Regenerative Medicine* (09:10) Applications and Public Interest in Stem Cell Therapy * (11:51) The Role of Exosomes in Regenerative Medicine * (14:46) Current Trends and Companies in Regenerative Medicine * (17:57) Promise vs. Peril in Regenerative Medicine * (21:04) Challenges in Clinical Trials and FDA Approval * (24:02) The Future of Regenerative Medicine * (26:57) Global Perspectives on Stem Cell Therapy * (30:01) The Role of Innovation in US Healthcare * (32:47) Conclusion and Future Directions Key Takeaways: * Regenerative medicine aims to restore health, not just eliminate disease. * Stem cells have been used in clinical settings for decades, primarily in oncology. * Exosomes play a crucial role in cell communication and regenerative therapies. * The public is increasingly interested in the applications of stem cell therapy. * Clinical trials are essential for proving the safety and efficacy of new treatments. * Innovation and funding are critical for advancing regenerative medicine. * The FDA plays a significant role in regulating stem cell therapies. * Different sources of stem cells can lead to different therapeutic outcomes. * The complexity of creating new organs presents challenges in regenerative medicine. * Global perspectives on stem cell therapy vary, with some countries advancing faster than others. ⁠ ⁠linkedin.com/in/robinlsmith-mdmba⁠ (linkedin.com/in/robinlsmith-mdmba)⁠linkedin.com/in/andrew-von-eschenbach-m-d-9439ab10⁠ (linkedin.com/in/andrew-von-eschenbach-m-d-9439ab10)⁠www.scale-community.com⁠ (www.scale-community.com) About the Guests: Dr. Robin L. Smith, doctor, author, and entrepreneur, is transforming healthcare through stem cell therapy, regenerative medicine, and predictive analytics. With expertise in M&A, FDA regulatory advancements, and industry turnarounds, she drives innovation and shapes the future of patient care. Dr. Andrew Von Eschenbach, M.D., former FDA Commissioner and NCI Director, advanced regulatory science, streamlined drug approvals, and prioritized innovation in medical products. His leadership focused on cancer research, prevention, and improving public health outcomes. Keywords: regenerative medicine, stem cell therapy, exosomes, FDA approval, clinical trials, healthcare innovation, oncology, musculoskeletal disease, tissue engineering, health restoration, Analyzing Healthcare, Roy Bejarano, Jason Schifman, Healthcare Leadership, Healthcare Trends

  5. FEB 27 · VIDEO

    Daniel Greenleaf, CEO of Duly Health on Leadership & AI Adoption in Healthcare

    Roy Bejarano sits down with Dan Greenleaf, CEO of Duly Health, to discuss the innovative strategies driving success in the healthcare industry. Dan shares his journey from the pharmaceutical and infusion industries to leading one of the largest independent multispecialty groups in the country. They dive into the importance of team alignment, improving patient experience, and the value of value-based care in driving cost efficiency and better patient outcomes. Dan also shares insights on how technology, including AI and ambient listening, is revolutionizing patient care and physician experiences. Tune in to learn how Duly is paving the way for the future of healthcare through innovation, patient-centered care, and cost-effective solutions.Key Timestamps:* (00:00) Introduction to Dan Greenleaf and Duly Health.* (01:21) Dan shares his unexpected journey to becoming the CEO of Duly Health.* (04:02) Discussing the importance of team alignment and the "right people in the right seats."* (07:06) The focus on patient experience, reducing friction, and achieving world-class Net Promoter Scores.* (12:30) Addressing access to care, cost efficiency, and patient convenience at Duly.* (18:21) Value-based care and its integration into Duly's operations.* (22:45) The transition from single specialty to multi-specialty practice and the challenge of balancing fee-for-service with value-based care.* (25:02) How technology and AI, such as ambient listening, are improving patient and physician experiences.* (30:30) Dan’s vision for the future of Duly, including the potential for direct-to-employer healthcare models.* (35:01) The importance of reducing healthcare system inefficiencies and monopolistic behavior.* (40:54) Global healthcare perspectives and what the U.S. can teach the world about cost efficiency and patient outcomes.Key Takeaways:* Team Alignment is Crucial: The key to improving any healthcare organization is ensuring the right people are in the right roles, fostering a high-performing team that is aligned with the organization’s goals.* Patient Experience Drives Success: Achieving high patient satisfaction and focusing on improving the patient journey are central to Duly's success, with world-class Net Promoter Scores.* Cost Efficiency through Value-Based Care: Duly’s focus on value-based care allows for significant cost savings and better patient outcomes, with a strong emphasis on patient access and convenience.* AI and Technology as Game-Changers: Technologies like ambient listening and AI-driven automation are transforming the clinical experience, improving efficiency, and reducing administrative burdens on physicians.Resources:* Duly Health: Learn more about Duly Health’s patient-centered care model⁠ here⁠.* SCALE-Community Website: https://www.scale-community.com/About the Guest:Dan Greenleaf is the CEO of Duly Health, the country’s largest independent multispecialty group, with over 1,000 primary and specialty care physicians. With extensive experience in both healthcare and pharmaceuticals, Dan has held multiple CEO positions across various sectors and is a strong advocate for improving patient care, reducing healthcare costs, and integrating value-based care. Under his leadership, Duly Health has become a model for healthcare innovation and patient-centered care.Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Jason Schifman, Healthcare Innovations, Healthcare Industry Insights,patient care, value-based care, healthcare innovation, health systems, cost efficiency, primary care, multi-specialty group, patient experience,

  6. FEB 24 · VIDEO

    Revolutionizing Senior Healthcare: Cairns Health CEO Andrew Ritter on Luna & the Future of Patient Monitoring

    In this episode, Jason Schifman sits down with Andrew Ritter, CEO of Cairns Health, to discuss innovative solutions in senior care and patient engagement. Andrew shares his journey from founding Ritter Pharmaceuticals to leading Cairns Health, a company dedicated to enhancing care through digital tools like Luna, a proactive health companion. Tune in to learn about the role of technology in home health care, the challenges of patient engagement, and how Luna is transforming the patient-caregiver relationship. Timestamps:* (00:00) Introduction to the podcast and guest* (00:29) Andrew Ritter’s background in healthcare and technology* (02:20) Transition from biotech to digital healthcare* (05:01) Introduction to Luna: The digital care companion* (08:03) Real-time monitoring and assessments with Luna* (10:09) Reducing healthcare risks through predictive data* (13:03) How Luna fits into home care and senior care models* (15:52) Case studies: Vitality and Alzheimer's patient focus* (19:36) Challenges in scaling digital solutions for healthcare* (22:29) The future of healthcare technology and Luna’s impact* (27:02) The potential for AI and voice recognition in senior care* (29:47) Competitive landscape and Cairns Health's unique approach* (32:05) The vision for the next 3-5 years in digital health Key Takeaways:* Proactive Patient Engagement: Luna serves as a digital companion that provides proactive health monitoring and communication between patients, caregivers, and providers, improving care and reducing caregiver burden.* Predictive Healthcare: By using advanced radar technology and AI, Luna helps predict potential health issues before they become critical, allowing for timely intervention.* Empowering Patients: Luna enables patients, particularly seniors, to take an active role in managing their healthcare through easy-to-use digital tools that enhance communication and care plan adherence.* Future of Healthcare Tech: The vision for digital healthcare is expanding beyond basic monitoring, aiming to create a comprehensive system where all health data is integrated to predict and prevent potential issues.About the Guest:Andrew Ritter, CEO of Cairns Health, shared his journey from biotech to digital healthcare. Through Luna, an autonomous radar system for non-intrusive patient monitoring, improving patient outcomes, and reducing the burden on caregivers, reshaping the future of healthcare.Resources:* Scale Community⁠ https://www.scale-community.com/⁠* Andrew Ritter ⁠linkedin.com/in/andrewritter⁠Healthcare, Healthcare Leadership, Healthcare Trends, Roy Bejarano, Jason Schifman, Healthcare Innovations, Healthcare Industry Insights, , Senior Care, Patient Engagement, Remote Monitoring, Digital Health, Healthcare Technology, Luna, AI in Healthcare, Senior Living, Home Care Technology

  7. FEB 19 · VIDEO

    CEO Leadership Series -Dr. Scott Hayworth on Innovation, Growth, and the Future of Medicine at CareMount & Optum

    In this episode of the Scale CEO Leadership Series, we sit down with Dr. Scott Hayworth, the former CEO of CareMount Medical, to discuss innovation, growth, and the future of medicine. With his wealth of experience in the healthcare industry, Dr. Hayworth shares valuable insights on leadership strategies, navigating healthcare transformation, and what the future holds for healthcare providers. Tune in to hear about the evolution of CareMount and how healthcare leaders are shaping the future of medicine.Timestamps:* [00:00] Introduction to the Scale CEO Leadership Series* [01:03] Dr. Hayworth’s background and CareMount acquisition by Optum* [04:26] Transition from fee-for-service to value-based care* [06:54] Managing multiple payment structures and supporting physicians* [08:31] Managing healthcare costs and ensuring better patient care* [12:15] Negotiating with Medicare and Medicare Advantage* [15:45] Data and analytics in healthcare negotiations* [18:11] Moving to Optum: Insights into the transition* [23:31] Differences between managing CareMount and Optum* [49:34] Addressing healthcare's rising costs and personal responsibilityKey Takeaways:* Leadership in Healthcare: Dr. Hayworth emphasizes the importance of visionary leadership in driving healthcare transformation and innovation.* Technology’s Impact: The integration of new technologies is essential for scaling healthcare organizations and enhancing patient care.* Creating a Culture of Innovation: Building a culture that encourages continuous improvement and innovation is key to thriving in the healthcare sector.* The Future of Healthcare: The future of medicine is centered around technology, personalized care, and a focus on preventive healthcare to improve overall patient outcomes.Guest Bio:Dr. Scott Hayworth, a distinguished OB-GYN and healthcare executive, has played a pivotal role in reshaping the U.S. healthcare system. As the former CEO of CareMount Medical, he expanded it into one of the largest independent medical groups. Under his leadership, CareMount transitioned to Optum, where he spearheaded major healthcare initiatives. His expertise spans clinical excellence, strategic growth, and healthcare innovation, making him a key voice in the industry's evolution.Resources:Scale Community https://www.scale-community.com/Dr. Scott Hayworth's LinkedIn

    About

    What’s next for healthcare? In a rapidly evolving industry, staying ahead requires insights, expert analysis, and actionable strategies. Analyzing Healthcare is the podcast for healthcare professionals, policymakers, investors, and curious citizens who want to navigate the challenges and opportunities shaping the future of healthcare. Analyzing Healthcare goes beyond theory to deliver real-world case studies and perspectives on the U.S. and global healthcare system. Hosted by industry experts Roy Bejarano and Jason Schifman, Co-Founders of SCALE Healthcare, the country’s leading healthcare services consulting firm, the podcast explores the ever changing world of our healthcare industry. Whether you’re eager to ignite new ideas, broaden your knowledge, or enjoy stimulating discussions, Analyzing Healthcare offers something for everyone. Each episode features thought-provoking conversations with healthcare political leaders, CEOs and innovators, to authors and visionaries, tackling today’s most pressing topics, including a macro understanding of how to evaluate our health system on a global basis, digital health advancements, artificial intelligence in healthcare, value-based care models, telemedicine trends, healthcare policy and regulatory changes. Learn how top professionals are improving patient outcomes, streamlining operations, and driving innovation in this dynamic field. Whether you’re focused on healthcare management, investing in healthcare services, or simply passionate about staying informed, this podcast empowers you with the tools and knowledge to succeed. Join us as we explore the subjects that influence all of our lives and encourage you to join the dialogue. Stay ahead of the curve—subscribe to Analyzing Healthcare with Roy Bejarano and Jason Schifman and explore the groundbreaking trends and strategies defining the future of healthcare. Head on over to www.scale-community.com to become a Scale Community Member. Join us next time, where stories, insights, and inspiration await. About the Hosts Roy Bejarano is the Co-Founder and CEO of SCALE Healthcare, named the #1 Fastest Growing Consulting Firm in the U.S. by Consulting Magazine in 2022. Since founding the company in 2019, Roy’s team has collaborated with hundreds of multi-site provider organizations and financial institutions, focusing on MSO operations, practice management, and strategic healthcare dynamics. Previously, Roy co-founded Frontier Healthcare, New York’s largest ASC management company at the time of its sale to Physicians Endoscopy/Kelso Private Equity. He also served as Chief Strategy Officer & Co-President of Physicians Endoscopy’s MSO initiative, leading its inaugural physician practice MSO partnership. Before entering healthcare, Roy gained over a decade of experience in investment banking, private equity, and strategic consulting with firms like Houlihan Lokey and Citigroup. A frequent author and speaker on healthcare trends, Roy has contributed to Fast Company, Physicians Practice, and Beckers and presented at leading industry conferences. Jason Schifman is the Co-Founder & President of SCALE Healthcare. SCALE provides both the broadest and deepest range of services & solutions available to multi-site healthcare management teams today, based on our fundamental belief that narrow, and/or purely theoretical solutions cannot solve for the multidisciplinary opportunities and challenges of today’s healthcare market. Jason is a trusted advisor to an extensive range of multisite healthcare organizations, Boards, CEOs, private equity investors and lenders across the healthcare market. He has advised stakeholders on a broad range of strategic, growth & development and operational objectives. Internally, Jason is focused on overseeing SCALE’s management leadership team, as well as leading the development and expansion of SCALE’s portfolio of services and innovation initiatives.

    You Might Also Like

    Content Restricted

    This episode can’t be played on the web in your country or region.

    To listen to explicit episodes, sign in.

    Stay up to date with this show

    Sign in or sign up to follow shows, save episodes, and get the latest updates.

    Select a country or region

    Africa, Middle East, and India

    Asia Pacific

    Europe

    Latin America and the Caribbean

    The United States and Canada